agilon health, inc. provided revenue guidance for the first quarter ending March 31, 2024. For the quarter, the company expects total revenues of $1,605 million to $1,630 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.26 USD | +1.35% | +8.90% | -58.09% |
May. 09 | Deutsche Bank Adjusts agilon health Price Target to $5 From $8, Maintains Hold Rating | MT |
May. 07 | Transcript : Agilon health, inc., Q1 2024 Earnings Call, May 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.09% | 2.16B | |
-18.17% | 3.09B | |
-15.24% | 2.95B | |
+6.53% | 234M | |
-46.54% | 174M | |
-33.52% | 115M |
- Stock Market
- Equities
- AGL Stock
- News agilon health, inc.
- Agilon health, inc. Provides Revenue Guidance for the First Quarter Ending March 31, 2024